Medicines and Healthcare
The University of Exeter Medical School, which is based in and around the Royal Devon and Exeter NHS Foundation Trust, has an excellent research reputation and works closely with the Exeter-based SW Academic Health Science.
A new £27m facility based at the RD&E.
The centre acts as:-
- Research Facility
- Post Graduation Education Centre
- GP Training Scheme Provision
- Learning & Development/Faculty of Health Service Provision
- Information Management & Technology Training Facility
This £60m interdisciplinary research centre will address the great challenges facing humanity: food security, lifelong health and wellbeing and a sustainable environment.
The building will house 20 different academic groups, 200 researchers and carry out research into three areas:
- Combating serious disease in humans, animals and plants
- Predicting the rapid evolution of pathogens & diseases
- Predicting and treating disease at the cellular level
It is due to open in 2016.
The Sir Henry Wellcome Building for Mood Disorders Research addresses key priorities in understanding and treating the whole 'spectrum' of mood disorders, including major depression and bipolar depression.
It was established in 2012 as the result of a £3.6m Capital Award from the Wellcome Trust. The Centre is a partnership of the NHS and the University of Exeter.
The American pharmaceutical consultancy, Quintiles, have appointed the SW of England as one of its “Prime sites” for clinical trials, taking in clinical research facilities and academics at the Peninsula College of Medicine and Dentistry; Devon Partnership NHS Trust; the Royal Devon & Exeter NHS Foundation Trust; Plymouth Hospitals NHS Trust; South Devon NHS Healthcare Trust; and Royal Cornwall Hospitals NHS Trust. This group of medical facilities makes up the Peninsula Prime Site.